Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Neoplasms 2Tuberculosis, Pulmonary 1Patient Satisfaction 1Pain 1Lung Neoplasms 1Hypoxia 1

Interventions

3-fluoro-2-(4-((2-nitro-1H-imidazol-1-yl)methyl)-1H-1,2,3-triazol-1-yl)propan-1-ol 6TH 302 4Radiotherapy 4pimonidazole 3fluoroazomycin arabinoside 3Propofol 3Injections 3Positron Emission Tomography Computed Tomography 2Blood Specimen Collection 2Bacterial Load 2pomalidomide 1pembrolizumab 1inositol trispyrophosphate 1gadobutrol 1fluoromisonidazole 1fludarabine 1Tirapazamine 1Temozolomide 1Sodium Chloride 1Sevoflurane 1Saline Solution 1Pancreaticoduodenectomy 1Paclitaxel 1Oxygen 1Nitroglycerin 1Nimorazole 1NVP-BKM120 1Metformin 1Magnetic Resonance Spectroscopy 1Ketamine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Hypoxia × Alfentanil × Clear all
NCT07395596 2026-02-24

Remimazolam for Bronchoscopy in High-Risk Patients

First Affiliated Hospital of Zhejiang University

Phase 4 Recruiting
360 enrolled

Hypoxia, Tuberculosis, Pulmonary

Data powered by HemOnc (CC BY 4.0) Colophon âš¡